引用次数
引用: 22,399
H-指数: 70
I10-指数 : 116
出版物: 297
Abstract B73: Molecular mechanisms of glioma resistance to EGFR tyrosine kinase inhibitors.
Jill E. Wykosky , Webster Cavenee , Frank Furnari
Molecular Cancer Therapeutics 10
2011
Abstract LB-110: Proteasome addiction a new therapeutic opportunity to treat PTEN-deficient brain tumors
Jorge A. Benitez , Darren Finlay , Alexandre Rosa-Campos , Jianhui Ma
Cancer Research
2019
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations.
Jill Wykosky , Tim Fenton , Frank Furnari , Webster K. Cavenee
Chinese Journal of Cancer 30 ( 1) 5 -12
68
2011
Decoy for microRNAs
Isidore Rigoutsos , Frank Furnari
Nature 465 ( 7301) 1016 -1017
34
2010
Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma
Kenji Tsuchihashi , Shogo Okazaki , Momoko Yoshikawa , Ryo Seishima
Cancer Research 77
2017
Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis
Clark Chen , David Kozono , Jie Li , Masayuki Nitta
Molecular Cancer Research 13
2015
Intron 1–Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins
Nathan M. Jameson , Jianhui Ma , Jorge Benitez , Alejandro Izurieta
Molecular Cancer Research 17 ( 11) 2208 -2220
1
2019
EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
Bipasha Mukherjee , Brian McEllin , Cristel V. Camacho , Nozomi Tomimatsu
Cancer Research 69 ( 10) 4252 -4259
301
2009
Epidermal growth factor receptor targeting and challenges in glioblastoma.
Amy Haseley Thorne , Ciro Zanca , Frank Furnari
Neuro-oncology 18 ( 7) 914 -918
73
2016
ATPS-86MUTATIONS IN THE EGF RECEPTOR EXTRACELLULAR DOMAIN REVEAL AN UNTETHERED TRANSITIONAL STATE WHICH MEDIATES mAb806 BINDING
Amy Haseley Thorne , Laura Orellana , Alison Parisian , Webster Cavenee
Neuro-oncology 17
2015
CBIO-04DAXX INHIBITION SUPPRESSES TUMOR GROWTH IN PTEN-DEFICIENT HUMAN GLIOBLASTOMAS
Jorge Benitez , Antonia Boyer , Fernanda Camargo , Ciro Zanca
Neuro-Oncology 17 ( suppl 5) v55.4 -v55
2015
Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas
Valya Ramakrishnan , Beibei Xu , Johnny Akers , Thien Nguyen
EBioMedicine 55 102736
7
2020
Abstract B37: Tumor heterogeneity contributes to anti-EGFR therapy resistance in glioblastoma
Ciro Zanca , Webster Cavenee , Frank Furnari
Cancer Research 75
2015
Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
Masayuki Nitta , David Kozono , Richard Kennedy , Jayne Stommel
PLOS ONE 6 ( 4)
2011
CSIG-25. EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR DOMAIN MISSENSE MUTATION A289V AS A DRIVER OF GLIOBLASTOMA INVASION AND PROLIFERATION
Zev Binder , Amy Thorne , Spyridon Bakas , E Paul Wileyto
Neuro-oncology 20
2018
DRES-08. DYNAMIC KINOME PROFILING OF GENETICALLY-DEFINED, EGFRvIII-DRIVEN MURINE ASTROCYTE MODELS OF GLIOBLASTOMA REVEALS TARGETS FOR DUAL KINASE INHIBITOR THERAPY
Erin Smithberger , Abigail Shelton , Madison Butler , Alex Flores
Neuro-oncology 20
2018
DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING
Abigail Shelton , Erin Smithberger , Madison Butler , Alex Flores
Neuro-oncology 20
2018
ATRT-08. SMARCB1 LOSS INTERACTS WITH NEURAL DIFFERENTIATION STATE TO GENERATE CELL TYPE-SPECIFIC PHENOTYPES
Alison Parisian , Tomoyuki Koga , Frank Furnari
Neuro-oncology 21
2019
TMOD-09. MODELING TERT PROMOTER MUTATION IN ISOGENIC NEXT GENERATION GBM MODELS
Shunichiro Miki , Tomoyuki Koga , Alison Parisian , Frank Furnari
Neuro-oncology 21
2019
TMOD-28. AUTHENTIC HUMAN GLIOMA MODELING USING GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS
Tomoyuki Koga , Isaac Chaim , Sebastian Markmiller , Jorge Benitez
Neuro-oncology 21
2019